You are here

Imbruvica

As Imbruvica bows out, AstraZeneca clinches early Calquence win in newly diagnosed MCL

Fierce Pharma

Thu, 05/2/24 - 11:31 am

mantle cell lymphoma

Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data

Xtalks

Mon, 02/5/24 - 10:17 am

Bristol Myers Squibb

Despite big Q2 declines for Humira and Imbruvica, AbbVie still boosts earnings guidance

Fierce Pharma

Thu, 07/27/23 - 11:37 pm

AbbVie sues BeiGene over brand-new Imbruvica patent as blood cancer rivalry heats up

Fierce Pharma

Fri, 06/16/23 - 09:44 am

AbbVie removes two approvals for blood cancer drug Imbruvica

BioPharma Dive

Fri, 04/7/23 - 01:49 pm

BeiGene's Brukinsa wins CLL approval after topping Imbruvica in head-to-head trial

Endpoints

Thu, 01/19/23 - 08:55 pm

BeiGene heaps more pressure on AbbVie, J&J with new Brukinsa head-to-head win over Imbruvica

Fierce Pharma

Wed, 10/12/22 - 11:00 am

AbbVie, J&J's Imbruvica wins first pediatric nod, this one for chronic graft-versus-host disease

Fierce Pharma

Thu, 08/25/22 - 11:04 am

graft vs host disease

Janssen's Imbruvica Demonstrates Significant Survival Outcomes In Older Lymphoma Patients

BioSpace

Mon, 06/6/22 - 10:03 am

clinical trials

ASCO: J&J, AbbVie go back to Imbruvica's roots in lymphoma. Will lack of survival win matter?

Fierce Pharma

Fri, 06/3/22 - 10:27 am

AbbVie files sNDA to FDA for chronic graft versus host disease therapy

Pharmaceutical Business Review

Tue, 03/1/22 - 10:24 am

graft vs host disease

ASH: Chasing AbbVie and J&J's Imbruvica, BeiGene's Brukinsa fleshes out competitive leukemia data again

Fierce Biotech

Thu, 11/4/21 - 10:27 am

clinical trials

Court upholds AbbVie's patents on blockbuster cancer drug Imbruvica, generics unlikely until 2032

Endpoints

Fri, 08/20/21 - 12:33 pm

In next-gen BTK battle, AbbVie and J&J tout pivotal data backing Imbruvica as a combo treatment

Endpoints

Mon, 06/14/21 - 10:29 am

clinical trials

This Is Why Humira Isn't AbbVie's Biggest Problem Right Now

Motley Fool

Mon, 05/3/21 - 10:55 am

AZ says Calquence is a safer drug than Imbruvica

Pharmaforum

Mon, 01/25/21 - 11:02 am

ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice

Fierce Pharma

Sun, 12/6/20 - 07:15 pm

Janssen gets expanded EC nod for blood cancer combo drug Imbruvica plus rituximab

Pharmaceutical Business Review

Tue, 09/8/20 - 10:41 am

AbbVie to face House committee subpoena over Humira, Imbruvica pricing strategies: chairwoman

Fierce Pharma

Tue, 09/1/20 - 12:28 pm

Pages